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Background:  Our aim was to measure the histologic and histomorphometric 
effects of PTH treatment on irradiated bone undergoing distraction osteogenesis 
(DO). 
 
Methods:  Thirty-four rats were divided into three groups.  The control group 
underwent DO and the radiation control group underwent radiation treatment 
(RT) prior to DO.  The PTH group underwent RT and received PTH during DO.  
Quantitative histology and histomorphometry was performed. 
  
Results:  RT resulted in a depletion of osteocytes and increase in empty 
lacunae.  Treatment with PTH resulted in an increase in osteocyte counts and 
decrease in empty lacunae (p< 0.05), restoring osteocytes to levels seen in non-
radiated bone (p=0.121).  RT decreased bone-volume-to-tissue-volume ratio and 
increased osteoid-volume-to-tissue-volume (OV/TV) ratio, signifying increased 
immature bone formation.  PTH treatment restored OV/TV ratio to that observed 
in non-radiated bone. 
 
Conclusions:  PTH treatment of irradiated bone enhanced bone regeneration 
and restored osteocyte counts and OV/TV ratio to levels comparable to non-
radiated bone. 
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Introduction 
 Radiation treatment is a critical component of the multidisciplinary 
management of head and neck cancer.  However, radiation treatment also 
severely damages surrounding tissue, impairs wound healing, and degrades 
bone within the treatment field 1-3.  Radiation treatment delivered to bone has 
been shown to cause immediate and delayed osteocyte death 1,2,4, decrease 
bone mineral density 5, decrease biomechanical strength 6, and impair osseous 
vascularity on a macroscopic and microscopic level 6-9.  The most severe form of 
osseous damage from radiation treatment occurs in the form of 
osteoradionecrosis 2 10, which remains a challenging clinical entity. 
 Adjunctive agents that enhance osseous healing in the irradiated field 
could be quite beneficial.  Parathyroid hormone (PTH) has emerged as a 
potential therapeutic agent as it has been shown to promote bone anabolism and 
is FDA approved in the treatment of osteoporosis 11.  However, while PTH has 
shown tremendous anabolic potential in patients with osteoporosis, more data 
are needed to determine if PTH can enhance osseous regeneration within 
irradiated bone.  If PTH were to enhance bone regeneration within an irradiated 
field, it could have tremendous therapeutic potential for clinical translation to 
patients with advanced oral cavity cancers requiring osseous free tissue transfer 
and adjuvant radiation treatment, as well as patients with osteoradionecrosis.   
In this study, we employ a murine model of distraction osteogenesis in 
order to study the histologic and histomorphometric effects of radiation treatment 
and intermittent PTH on the regenerate bone.  We hypothesize that radiation 
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treatment will result in decreased osteocyte levels, increased empty lacunae, and 
replacement of mature, mineralized bone with immature, osteoid formation.  We 
further hypothesize that treating irradiated bone with intermittent PTH will reverse 
these radiation-induced effects, restoring histological and histomorphometric 
architecture similar to that of non-radiated bone.  
 
Materials and Methods 
Experimental Groups 
Thirty-four twelve-week-old isogenic male Lewis rats were randomly 
assigned to one of three experimental groups: DO, xDO, and xDO-PTH (Figure 
1).  All groups underwent surgical placement of mandibular distractors and 
underwent mandibular distraction osteogenesis.  The DO (n=12) group was the 
normal control group and underwent mandibular distraction osteogenesis.  The 
DO group did not receive radiation treatment.  The xDO (n=10) group was the 
radiation control group and received preoperative radiation treatment followed by 
mandibular distraction osteogenesis.  The xDO-PTH (n=12) group received 
preoperative radiation treatment followed by mandibular distraction osteogenesis 
and intermittent subcutaneous PTH (60 µg/kg, once daily) beginning on the first 
day of distraction for a total duration of 21 days.  Our animal protocol has been 
reviewed and approved by the University Committee on the Use and Care of 
Animals.  The experimental timeline is shown in Figure 2.  
Radiation Treatment 
Rats were acclimated for 7 days in light and temperature controlled 
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facilities and given hard chow and water without restriction. Radiation was 
delivered to the xDO and xDO-PTH groups; the DO group did not receive 
radiation.  Prior to radiation, rats were anesthetized with inhaled isoflurane.  
Induction was begun at 4%, after which anesthesia was maintained at 1.5%.   
All radiation treatments were performed in the Irradiation Core at the 
University of Michigan Cancer Center using a Philips R250 orthovoltage unit 
(250kV, 15 mA; Kimtron Medical, Woodbury, CT).  Radiation was delivered to the 
left hemimandible, 2-mm posterior to the third molar.  Lead shielding was used to 
ensure localized delivery and to protect surrounding tissue.  7 Gy was delivered 
daily for 5 days for a total fractionated treatment dose of 35 Gy, which is the 
bioequivalent dose of 70 Gy in humans [30].  Dosimetry was carried out using an 
ionization chamber connected to an electrometer system, which was directly 
traceable to a National Institute of Standards and Technology calibration.   
After completion of radiation, the xDO-PTH and xDO groups were allowed 
to recover for 14 days.  During this period, all three groups were acclimated to a 
soft chow high-calorie diet (Hills-Columbus Serum; Columbus, Ohio).  The 
percent of ration of calcium and phosphorus were 0.95% and 1.05% respectively, 
and the content of vitamin D was 4.5 IU per gram.   
Surgery and Postoperative Care  
 All three groups underwent surgical placement of a mandibular distraction 
device with unilateral left mandibular osteotomy.  The details of the surgical 
procedure have been previously described in detail 12.  The surgery was 
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performed 14 days after completion of radiation in the xDO-PTH and xDO 
groups.  Anesthesia was achieved with inhalational isoflurane (4% induction, 
1.5% maintenance) and subcutaneous buprenorphine (0.3 mg/kg).  A single dose 
of subcutaneous gentamicin (5 mg/kg) was given preoperatively.  
Postoperatively, rats were given two doses of subcutaneous gentamicin (5 
mg/kg) every 12 hours to prevent infection.  Subcutaneous buprenorphine (0.03 
mg/kg) was given every twelve hours through postoperative day (POD) 5.  
Staples were removed at POD 10.  Weights were measured daily and 
subcutaneous lactated ringer solution was delivered as needed.  Pin care was 
provided with Silvadene (Monarch Pharmaceuticals, Inc., Bristol, TN).  Maxillary 
incisors were clipped weekly because of overgrowth from crossbite.   
Mandibular Distraction Osteogenesis and Region of Interest 
All rats began left mandibular distraction osteogenesis on POD 4.  
Distraction was performed at a rate of 0.3 mm every 12 hours to a total 
distraction gap of 5.1 mm.  The 5.1 mm distraction gap was chosen because it is 
a critical size defect in the murine mandible and was previously shown to  be 
reliably distracted with complete bony union 12.  The final distraction was 
completed on POD 12.  Subjects then underwent a 28-day consolidation period 
prior to sacrifice and histological analysis.  
Parathyroid Hormone  
Intermittent recombinant human PTH (1-34) (Bachem, CA) was 
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administered to the xDO-PTH group in the postoperative period, beginning on the 
first day of distraction (POD 4).  PTH (60 µg/kg) was delivered in intermittent 
fashion, once daily, and was injected subcutaneously over the right hindlimb.  
Treatment duration was 3 weeks; a total of 21 doses were delivered and 
treatment was completed on POD 25.  The PTH treatment dose and duration 
employed in this study has previously been shown to improve vascularity, union 
quality, bone mineral density, and bone volume fraction in a similar murine model 
of DO 5,9. 
Tissue Harvest 
 
 Specimens were processed and embedded following a protocol previously 
described 13.  Bone formed within the 5.1 mm distraction gap was isolated and 
selected as our region of interest (ROI) for histologic analysis.  Coronal sections 
of the ROI were performed at a thickness of 7 µm, using a Leica Reichert-Jung 
2030 Biocut Microtome (Leica, Wetzlar, Germany).  After the sections were 
mounted on glass slides, every seventh slide was stained with Gomoro one-step 
trichom .  Two slides representative of the mid gap of the ROI were selected per 
specimen for histologic analysis.   
Quantitative Histomorphometry 
Digital color analysis 
 Using the imaging analysis software program Bioquant NOVA Osteo 
version 7 (R&M Biometrics, Nashville, TN), digital images of each slide were 
obtained for the placement of a standard template over the ROI and color 
thresholding.  The digital color analysis thresholds a blue-green color to the 
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mature, mineralized bone color, and a red-pink color to the osteoid, or immature 
bone.  Two images for each slide are then created, one image where mature, 
mineralized bone is replaced by red overlay, and another image where osteoid is 
replaced by red overlay.  Three independent reviewers, who were blinded with 
respect to the treatment groups, reviewed these images and obtained the 
following: 
• Tissue volume, representing the total volume of the ROI template. 
• Bone volume, representing the volume of mineralized bone within the ROI. 
• Osteoid volume, representing the volume of nonmineralized, immature 
bone and vacuoles within the ROI. 
Bone volume to tissue volume and osteoid volume to tissue volume ratios were 
calculated using the Bioquant software. 
Union After Distraction Osteogenesis 
Union of the regenerate region was determined by three blinded and 
independent reviewers. The presence of a union was defined as a solid bony 
bridging, in addition to an absence of motion across the distraction osteogenesis 
gap. 
Point Counting of Osteocytes and Empty Lacunae 
 Using the Bioquant software, the ROI was superimposed onto the digital 
image.  Nine high-power-field images at 16x magnification were randomly 
selected and stored as Tagged Image File Format files.  Point counting of 
osteocyte and empty lacunae was performed by three independent reviewers, 
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who were blinded with respect to the treatment groups.  Osteocytes were single 
cells that resided within lacunae. 
 
Statistical Analysis 
 Statistical analysis was performed using SPSS Statistics software V. 20 
(IBM; Armonk, NY).  The data were compared using one-way analysis of 
variance (ANOVA).  Post-hoc analysis was performed by either Tukey or Games-
Howell method, depending on the homogeneity of variances.  Significance was 
assigned as p < 0.05. 
 
Results 
Union After Distraction Osteogenesis 
 Union rate in the DO, xDO and xDO-PTH groups are shown in Figure 3. 
The non-radiated control group (DO group) exhibited complete union in all 
specimens (100%).  In contrast, the union rate in the group that received 
radiation treatment (xDO group) was considerably reduced, as only 43% of these 
mandibles formed a complete union.  However, the addition of PTH to irradiated 
bone (xDO-PTH) improved the union rate to 80% (Figure 3). 
 
Quantitative histologic analysis 
 Figure 4 shows representative histologic samples from the non-radiated 
group (DO group), radiation treated group (xDO group), and the radiation treated 
group receiving intermittent PTH (xDO-PTH group).  Compared to the DO group, 
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radiation treatment resulted in a significant decrease in osteocyte count and 
increase in empty lacunae.  The group receiving radiation treatment and PTH 
(xDO-PTH) showed osteocyte counts that were restored to non-radiated levels.  
Empty lacunae were significantly decreased in the xDO-PTH group compared to 
the xDO group, although empty lacunae were not decreased to non-radiated 
levels (Figures 4 and 5). 
In all quantitative metrics, a significant difference was identified between 
treatment groups as determined by one-way ANOVA (p<0.05).  As expected, 
radiation treatment group (xDO) resulted in a significant depletion of osteocytes 
and a significant increase in empty lacunae when compared to the non-radiated 
control group (DO).  Specifically, compared to the DO group, the xDO group 
showed a greater than 2-fold decrease in osteocyte count after radiation 
treatment (67.9 v. 139.3, p<0.001).  The xDO group showed a greater than 5-fold 
increase in empty lacunae after radiation treatment, compared to the non-
radiated DO group (12.3 v. 2.36, p=0.001) (Figure 5).  
 Treatment of radiated bone with intermittent PTH resulted in significant 
restoration of osseous cellularity, resulting in reversal of radiation-induced 
hypocellularity in the xDO-PTH group (radiation treatment followed by distraction 
and intermittent PTH).  Specifically, compared to the non-PTH treated radiation 
group (xDO), treatment with PTH resulted in a 1.84-fold increase in osteocyte 
count (125.0 v. 67.9, p<0.001).  Furthermore, compared to the xDO group, the 
xDO-PTH group had a 2.6-fold decrease in empty lacunae after PTH treatment 
(4.67 v. 12.3, p=0.005) (Figure 5). 
Page 12 of 31
John Wiley & Sons, Inc.
Head & Neck
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
PTH reverses radiation-induced hypocellularity during distraction osteogenesis 
 
 13
Intermittent treatment with PTH after radiation treatment in the xDO-PTH 
group resulted in a significant restoration of osteocytes to levels observed in the 
non-radiated DO group. There were no measurable differences in osteocyte 
count between non-radiated and distracted bone (DO group) and bone 
undergoing radiation treatment and intermittent PTH treatment (xDO-PTH group).  
Specifically, there was no significant difference in osteocyte count between the 
non-radiated DO group and the group undergoing radiation treatment followed by 
intermittent PTH (xDO-PTH) (139.3 v. 125.0, p=0.121) (Figure 5).  While 
treatment with PTH significantly decreased the number of empty lacunae 
compared to the radiation control group, treatment with PTH did not restore 
empty lacunae levels to non-radiated levels (4.67 v. 2.36, p<0.05). 
 
Histomorphometry 
 Compared to the DO group, radiation treatment in the xDO group resulted 
in a significant decrease in mature bone formation as determined by 
histomorphometry.  Representative histomorphometric samples from the DO, 
xDO, and xDO-PTH groups are shown in Figure 6.  Specifically, compared to the 
DO group, radiation treatment in the xDO group resulted in a 1.6-fold decrease in 
bone volume to tissue volume ratio (BV/TV), (0.331 v. 0.516, p=0.008).  The xDO 
group also showed an increase in immature bone formation as determined by 
osteoid volume to tissue volume ratio (OV/TV).  Specifically, compared to the DO 
group, radiation treatment resulted in a 1.7-fold increase in immature bone 
formation as measured by OV/TV (0.257 v. 0.149, p=0.024) (Figure 7). 
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 Compared to the xDO group, treatment with PTH was able to increase the 
bone volume to tissue volume ratio in the xDO-PTH group, but this difference 
was not significant (0.4171 v. 0.3483, p=0.420).  Similarly, treatment with PTH 
decreased immature bone formation as determined by osteoid volume to tissue 
volume ratio, but this difference was also not significant (0.1837 v. 0.2572, 
p=0.178) (Figure 7). 
 While radiation treatment resulted in a significant increase of immature 
bone formation as determined by osteoid volume to tissue volume ratio in the 
xDO and DO groups, treatment with PTH lessened this radiation-induced effect.  
Specifically, in comparison to the non-radiated DO group, the xDO-PTH group 
showed no significant difference in OV/TV (1.837 v. 1.491, p=0.345).  However, 
while PTH treatment was able to reduce the effect of radiation on bone volume 
loss, it was unable to completely reverse the BV/TV ratio to non-radiated levels.  
Specifically, compared to the DO group, the xDO-PTH group showed a 
significant decrease in BV/TV ratio (0.4171 v. 0.516, p=0.026) (Figure 7). 
 
Discussion 
 Radiation treatment has been shown to result in poorer regenerate 
outcomes in mandibular distraction osteogenesis 5,9,14-16, and this study 
confirmed that radiation treatment results in a significant depletion of osseous 
cellularity in a murine model of distraction osteogenesis.  However, treatment of 
radiated bone with intermittent PTH reversed radiation induced hypocellularity.  
In fact, PTH restored osteocyte counts in irradiated bone to baseline levels, as 
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there was no significant difference in osteocyte count between the irradiated 
group that received PTH (xDO-PTH group) and the group that underwent 
distraction alone, without radiation treatment (DO group).  Treatment with PTH 
also increased the degree of mature bone formation within the region of interest, 
although this was not restored to normal control levels.  Previous work has 
shown that PTH improves biomechanical strength 6, union quality, bone mineral 
density 5, and osseous vascularity 9 in irradiated bone.  This is the first report to 
demonstrate the ability of PTH to increase mature bone formation and restore 
osteocyte count to non-radiated levels in bone. 
 While the complete cellular mechanism by which PTH promotes bone 
anabolism remains to be elucidated, PTH has been shown to have a pleiotropic 
anabolic effect on bone formation 17, increasing osteoblast number by promoting 
osteoblastogenesis, inhibiting osteoblast apoptosis, and reactivating lining cells 
to resume matrix synthesizing function 17,18.  Radiation treatment specifically 
reduces proliferation of vasculature and osteoblasts 19.  While more studies are 
needed to determine the mechanism by which PTH ameliorates the effects of 
radiation treatment, the findings of this study clearly demonstrate the ability of 
PTH to preserve and restore osteocyte counts in irradiated bone to levels that 
are comparable to non-radiated bone.  
 Teriparatide, also known as recombinant human PTH (1-34), is an 
attractive adjunctive agent to study because it is already in clinical use and a 
U.S. Food and Drug Administration-approved therapy for osteoporosis 11,20,21.  
With regard to potential therapeutic use for osseous wounds in the head and 
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neck, Bashutski et al. 22 used intermittent PTH to accelerate alveolar bone 
regeneration in the oral cavity after periodontal surgery, evidenced by a 
significant radiographic improvement in linear resolution of osseous defects as 
well as a reduction in probing depth.  Case reports suggest that PTH may have a 
role in treating bisphosphonate-related osteonecrosis of the jaw 14,23,24.  These 
findings suggest tremendous therapeutic potential as an adjunctive treatment to 
complex wounds in the head and neck, where osseous wound healing is of 
paramount importance to functional outcome. 
 However, one large clinical hurdle exists, as a history of radiation 
treatment delivered to bone is currently a contraindication to PTH treatment 25,26.  
This contraindication exists due to the observation of osteosarcoma in rats 
chronically treated with PTH 27.  However, the animals in that particular study 
were treated at higher doses than those used in human studies, and for time 
spans up to 2 years, representing 80-90% of their normal time span, complicating 
comparisons to clinical trials that use short-term use of PTH.  The same authors 
studied PTH-related osteosarcoma in monkeys treated with daily PTH, and 
reported zero cases of osteosarcoma 28 suggesting that this effect may be 
species-dependent and not applicable to human subjects 26.  Harper et al. 
reported one case of osteosarcoma among >300,000 patients worldwide that 
have been treated with teriparatide (PTH) 24.  As a result, causality between 
teriparatide and osteosarcoma in humans has yet to be established.  However, 
the safety of teriparatide use in patients with a history of head and neck cancer 
and/or radiation treatment delivered to the mandible remains to be determined. 
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 This study adds to a growing literature demonstrating that PTH has 
tremendous potential to enhance osseous regeneration in irradiated bone.  PTH 
has previously been shown to enhance biomechanical strength, bone mineral 
density, and union formation in irradiated bone 5,6.  This histologic and 
histomorphometric study adds new data, demonstrating the ability of PTH to 
reverse radiation induced hypocellularity and enhance mature bone formation in 
a murine model of distraction osteogenesis, and further supports the potential 
use of PTH to enhance osseous regeneration in the irradiated mandible. 
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Figure 1.  Experimental groups.  The DO group underwent mandibular 
distraction alone, without radiation treatment.  The xDO group underwent 
radiation treatment followed by mandibular distraction.  The xDO-PTH group 
underwent radiation treatment, mandibular distraction, and intermittent PTH 
treatment for 21 days.  DO, distraction osteogenesis; Gy, gray; PTH, parathyroid 
hormone. 
 
Figure 2.  Experimental timeline.  In the xDO-PTH group, intermittent 
subcutaneous parathyroid hormone (PTH) treatment was given daily for 21 days 
beginning on the first day of mandibular distraction.  XRT, radiation treatment; 
DO, distraction osteogenesis; PTH, parathyroid hormone. 
 
Figure 3.  Union rate in the DO, xDO, and xDO-PTH groups. Union rate was 
ascertained based on clinical assessment of the regenerate for bony bridging 
without motion in the distraction osteogenesis gap. The DO (no radiation 
treatment) group had a 100% bony union rate, while the xDO (radiation 
treatment) group only formed a bony union in 43% of specimens.  The xDO-PTH 
group (radiation treatment + PTH) formed complete unions in 80% of specimens.  
 
Figure 4.  Representative sections of formation during distraction osteogenesis 
in non-radiated bone (DO), irradiated bone (xDO), and irradiated bone treated 
with PTH (xDO-PTH).  Specimens were stained with Gomori trichrome and are 
shown at 16x magnification.  Radiation treatment in the xDO group resulted in a 
Page 21 of 31
John Wiley & Sons, Inc.
Head & Neck
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
PTH reverses radiation-induced hypocellularity during distraction osteogenesis 
 
 22
significant depletion of osteocytes and increase in empty lacunae.  However, 
treatment of irradiated bone with PTH (xDO-PTH) resulted in a significant 
increase in osteocyte count and decrease in empty lacunae.  There was no 
significant difference in osteocyte count in non-radiated bone (DO) and irradiated 
bone treated with PTH (xDO-PTH).  The black arrow shows an osteocyte 
residing within a lacunae and the red arrow shows an empty lacunae. 
 
Figure 5.  Quantitative histologic analysis.  Radiation treatment resulted in a 
significant depletion of osteocytes in the xDO group when compared to non-
radiated group (DO) (p<0.001).  Treatment of irradiated bone with PTH resulted 
in a significant increase osteocyte counts (p<0.001).  In fact, no significant 
difference in osteocyte count existed between the non-radiated group (DO) and 
the irradiated group treated with PTH (xDO-PTH) (p= 0.121).  Y axis represents 
osteocytes per high power field.  With regard to empty lacunae, radiation 
treatment in the xDO group resulted in a significant increase in empty lacunae 
compared to non-radiated bone (p=0.001).  Treatment with PTH in the xDO-PTH 
group resulted in a significant decrease in empty lacunae (p=0.005), albeit not to 
levels seen in non-radiated bone.  Y axis represents empty lacunae per high 
power field.   
 
Figure 6.  Representative digital images used for histomorphometric assessment 
obtained by the imaging analysis software program Bioquant NOVA Osteo 
version 7 (R&M Biometrics, Nashville, TN) to quantitatively assess the ratio of 
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mature, mineralized bone formation to immature osteoid formation within the 
region of interest.  In the Standard column, mature, mineralized bone is 
represented by turquoise while osteoid is represented in pink-purple.  In the Bone 
Volume column, red overlay represents mature mineralized bone formation.  In 
Osteoid Volume column, red overlay represents immature, osteoid formation.  
These representative images show that compared to non-radiated bone (DO 
group), radiation treatment (xDO group) results in decreased mature bone 
formation and greater osteoid formation.  Treatment with PTH (xDO-PTH group) 
attenuates the effect of radiation treatment, resulting in greater areas of mature, 
mineralized bone formation, and less osteoid formation in irradiated bone 
undergoing distraction osteogenesis (DO).  When treated with PTH, the pattern 
of bone formation in irradiated bone undergoing DO is strikingly similar to non-
radiated bone.  
 
Figure 7.  Quantitative histomorphometric analysis.  Compared to the non-
radiated DO group, radiation treatment in the xDO group resulted in a significant 
decrease in bone-volume-to-total-volume ratio (BV/TV) (p=0.008).  Treatment of 
irradiated bone with PTH resulted in an increase in BV/TV, but this difference 
was not significant (p=0.420).  Radiation treatment resulted in a significantly 
greater osteoid-volume-to-total-volume (OV/TV) in the xDO group, compared to 
the non-radiated DO group (p=0.024).  Treatment of irradiated bone with PTH 
resulted in a decrease in OV/TV, but this difference was not significant (p=0.178).  
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However, there was no detectable difference in OV/TV between the non-radiated 
DO group and the irradiated group treated with PTH (p=0.345).   
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Figure 1.  Experimental groups.  The DO group underwent mandibular distraction alone, without radiation 
treatment.  The xDO group underwent radiation treatment followed by mandibular distraction.  The xDO-
PTH group underwent radiation treatment, mandibular distraction, and intermittent PTH treatment for 21 
days.  DO, distraction osteogenesis; Gy, gray; PTH, parathyroid hormone.  
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Figure 2.  Experimental timeline.  In the xDO-PTH group, intermittent subcutaneous parathyroid hormone 
(PTH) treatment was given daily for 21 days beginning on the first day of mandibular distraction.  XRT, 
radiation treatment; DO, distraction osteogenesis; PTH, parathyroid hormone.  
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Figure 3.  Union rate in the DO, xDO, and xDO-PTH groups. Union rate was ascertained based on clinical 
assessment of the regenerate for bony bridging without motion in the distraction osteogenesis gap. The DO 
(no radiation treatment) group had a 100% bony union rate, while the xDO (radiation treatment) group only 
formed a bony union in 43% of specimens.  The xDO-PTH group (radiation treatment + PTH) formed 
complete unions in 80% of specimens.  
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Figure 4.  Representative sections of formation during distraction osteogenesis in non-radiated bone (DO), 
irradiated bone (xDO), and irradiated bone treated with PTH (xDO-PTH).  Specimens were stained with 
Gomori trichrome and are shown at 16x magnification.  Radiation treatment in the xDO group resulted in a 
significant depletion of osteocytes and increase in empty lacunae.  However, treatment of irradiated bone 
with PTH (xDO-PTH) resulted in a significant increase in osteocyte count and decrease in empty 
lacunae.  There was no significant difference in osteocyte count in non-radiated bone (DO) and irradiated 
bone treated with PTH (xDO-PTH).  The black arrow shows an osteocyte residing within a lacunae and the 
red arrow shows an empty lacunae.  
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Figure 5.  Quantitative histologic analysis.  Radiation treatment resulted in a significant depletion of 
osteocytes in the xDO group when compared to non-radiated group (DO) (p<0.001).  Treatment of 
irradiated bone with PTH resulted in a significant increase osteocyte counts (p<0.001).  In fact, no 
significant difference in osteocyte count existed between the non-radiated group (DO) and the irradiated 
group treated with PTH (xDO-PTH) (p= 0.121).  Y-axis represents osteocytes per high power field.  With 
regard to empty lacunae, radiation treatment in the xDO group resulted in a significant increase in empty 
lacunae compared to non-radiated bone (p=0.001).  Treatment with PTH in the xDO-PTH group resulted in a 
significant decrease in empty lacunae (p=0.005), albeit not to levels seen in non-radiated bone.  Y-axis 
represents empty lacunae per high power field.    
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Figure 6.  Representative digital images used for histomorphometric assessment obtained by the imaging 
analysis software program Bioquant NOVA Osteo version 7 (R&M Biometrics, Nashville, TN) to quantitatively 
assess the ratio of mature, mineralized bone formation to immature osteoid formation within the region of 
interest.  In the Standard column, mature, mineralized bone is represented by turquoise while osteoid is 
represented in pink-purple.  In the Bone Volume column, red overlay represents mature mineralized bone 
formation.  In Osteoid Volume column, red overlay represents immature, osteoid formation.  These 
representative images show that compared to non-radiated bone (DO group), radiation treatment (xDO 
group) results in decreased mature bone formation and greater osteoid formation.  Treatment with PTH 
(xDO-PTH group) attenuates the effect of radiation treatment, resulting in greater areas of mature, 
mineralized bone formation, and less osteoid formation in irradiated bone undergoing distraction 
osteogenesis (DO).  When treated with PTH, the pattern of bone formation in irradiated bone undergoing DO 
is strikingly similar to non-radiated bone.  
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Figure 7.  Quantitative histomorphometric analysis.  Compared to the non-radiated DO group, radiation 
treatment in the xDO group resulted in a significant decrease in bone-volume-to-total-volume ratio (BV/TV) 
(p=0.008).  Treatment of irradiated bone with PTH resulted in an increase in BV/TV, but this difference was 
not significant (p=0.420).  Radiation treatment resulted in a significantly greater osteoid-volume-to-total-
volume (OV/TV) in the xDO group, compared to the non-radiated DO group (p=0.024).  Treatment of 
irradiated bone with PTH resulted in a decrease in OV/TV, but this difference was not significant 
(p=0.178).  However, there was no detectable difference in OV/TV between the non-radiated DO group and 
the irradiated group treated with PTH (p=0.345).    
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